A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver
The primary question of interest is quantifying the relationship between Y-90 liver therapy and liver damage.
The purpose of this study is to look at the safety of radioembolization therapy with Yttrium 90 for liver disease.
- IRB Number: 1606072855 (RADY-BTG-TANN-HIDA/0603)
- Research Study Identifier: TX7335
- Principal Investigator: Mark Tann, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required